Cantor Fitzgerald’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Cantor Fitzgerald’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,000	Closed	-$409K	–	928
2022 Q3	$409K	Buy	+6,000	New	+$331K	0.01%	529
2022 Q2	–	Sell	-6,000	Closed	-$208K	–	905
2022 Q1	$208K	Buy	+6,000	New	+$179K	0.02%	255

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cantor Fitzgerald's GBT Position: Q4 2022 in Review

Cantor Fitzgerald sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 6,000 shares — an estimated $409K sold.

Cantor Fitzgerald first reported a position in GBT in Q1 2022 and held it in 2 quarters. The position peaked at $409K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Cantor Fitzgerald reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Cantor Fitzgerald sold 6,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $409K.
Cantor Fitzgerald first reported a position in Global Blood Therapeutics, Inc. in Q1 2022 and held it in 2 quarters.
Cantor Fitzgerald's Global Blood Therapeutics, Inc. position peaked at $409K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Cantor Fitzgerald's 13F filing for Q4 2022, filed 14 Feb 2023.